Business Insights

The developing networked pharma model

Life Sciences

Pharmaceutical Outsourcing

The pharmaceutical industry is facing spiraling costs of developing new drugs while R&D productivity has stalled. In an effort to counteract this, pharmaceutical companies have outsourced work to third parties both in their home markets and offshore in emerging markets like India and China.

By focusing on the comparison of essential metrics in relation to the outsourcing of drug R&D, manufacturing, and sales, Business Insights identifies the key trends to help clients make the best possible outsourcing decisions.

Business Insights’ pharmaceutical outsourcing reports analyze key aspects of the pharmaceutical value chain, including:

  • Best practice in clinical trial location to ensure efficient recruitment and cost control
  • Analysis of leading players in the contract research, manufacturing, and sales industries
  • Regulatory requirements of outsourced projects in new clinical trial locations
  • Analysis of key strategies employed by leading players in the pharmaceutical and biotech industries when developing partnerships with CROs and CMOs.

The networked pharma model

Pharmaceutical Outsourcing reports

These are our most recently published Pharmaceutical Outsourcing reports. To view all the reports we publish on this subject please visit our Store or existing users can access them via their Interactive service.